NR 536 Week 3 Developing Critical Thinking Questions

Student Name

Chamberlain University

NR-536: Advanced Health Assessment, Pathophysiology & Pharmacology for Advanced Nursing Practice

Prof. Name

Date

Week 3 Assignment: Developing Critical Thinking Questions

Concept to be Presented: Protection and Movement – Infections

This week’s task focuses on developing critical thinking questions associated with the theme of protection and movement, emphasizing infection control — specifically ventilator-associated pneumonia (VAP). The selected learner is a staff nurse working in an acute care hospital, possessing three years of clinical experience in infection control and patient safety. Building critical thinking skills in this context enhances nurses’ decision-making ability, contributing to better patient outcomes and more effective strategies for preventing hospital-acquired infections (HAIs) such as VAP.

Problem Recognition

A 65-year-old male was admitted to the hospital with chest pain and subsequently diagnosed with localized pleuritis. The healthcare facility reports a hospital-acquired pneumonia (HAP) rate of 3.8%, highlighting a substantial risk of developing VAP among mechanically ventilated patients. The central clinical aim is to reduce infection rates through evidence-based interventions, ensuring improved patient safety and care quality.

Table 1: Critical Thinking Questions for Problem Recognition

Pathophysiology	Physical Assessment	Pharmacology
Question: What are the underlying reasons for the elevated VAP rates in this healthcare setting?Answer: Several factors can lead to higher VAP rates, including poor infection control measures, inadequate oral hygiene, and suboptimal hand hygiene compliance. Additionally, prolonged intubation, incorrect ventilator positioning, and frequent antibiotic use contribute to increased infection risk. Early intervention protocols and adherence to hygiene standards can mitigate these factors (Hua et al., 2016; Khan et al., 2017).	Question: What physical assessment practices are essential to reduce bacterial accumulation in the respiratory tract?Answer: Nurses must routinely assess lung sounds, airway patency, and sputum characteristics. Monitoring every 24–48 hours assists in identifying early infection indicators such as changes in breath sounds or sputum color. Early detection promotes timely interventions, improving patient outcomes (Álvarez-Lerma et al., 2018).	Question: Has antimicrobial resistance contributed to rising VAP incidence?Answer: Yes. Inappropriate or excessive antibiotic use promotes the development of multidrug-resistant organisms. Elderly and critically ill patients are particularly vulnerable to such infections, resulting in prolonged recovery and increased mortality (Zampieri et al., 2015).

Clinical Decision Making

To address the growing concern of VAP, the hospital implemented a VAP prevention bundle—an evidence-based collection of interventions aimed at minimizing infection risk. This bundle focuses on elevating the head of the bed, daily sedation breaks, oral hygiene, and subglottic suctioning. Integrating these practices with robust clinical reasoning enables nurses to make data-driven decisions, improving patient safety and reducing the economic burden associated with extended hospitalizations.

Table 2: Critical Thinking Questions for Clinical Decision Making

Pathophysiology	Physical Assessment	Pharmacology
Question: What evidence supports the use of the VAP prevention bundle?Answer: Research consistently shows that implementing a structured VAP bundle significantly lowers infection incidence. Strategies like maintaining the head-of-bed elevation at 30–45 degrees, ensuring oral care with antiseptic solutions, and minimizing ventilator circuit changes enhance infection control (Álvarez-Lerma et al., 2018; Pinho et al., 2020).	Question: When should patient assessments ideally occur to identify early respiratory complications?Answer: Patients should be assessed within 24 hours of intubation and continuously monitored thereafter. Since VAP typically develops after 48 hours of mechanical ventilation, timely assessment allows for early intervention and prevents progression to severe respiratory infections (Fortaleza et al., 2020).	Question: How does an extended hospital stay affect the efficacy of the VAP prevention bundle?Answer: Extended hospitalization increases the risk of antibiotic resistance and secondary infections. Integrating probiotic therapy with bundle components can enhance immunity, reduce bacterial colonization, and improve the overall efficacy of VAP prevention strategies (Xie et al., 2019; Zhao et al., 2020).

Prioritization and Clinical Intervention

The interdisciplinary care team identified continuous patient monitoring within the first 24 hours of intubation as a top priority to reduce VAP risk. Nursing workload and mental fatigue were considered in designing the interventions. Multimodal strategies—such as early mobilization, regular patient repositioning, sedation control, and comprehensive oral care—were implemented to optimize respiratory function and prevent bacterial growth in the airway.

Table 3: Critical Thinking Questions for Prioritization and Clinical Intervention

Pathophysiology	Physical Assessment	Pharmacology
Question: What early warning signs suggest that a patient requires closer monitoring for VAP?Answer: Early indicators include fever, increased respiratory rate, oxygen desaturation, crackles on auscultation, and purulent sputum production. Recognizing these signs early enables timely initiation of antibiotic therapy and supportive measures (Álvarez-Lerma et al., 2018).	Question: What ventilator positioning helps reduce infection risk?Answer: Keeping the head of the bed elevated at approximately 30 degrees minimizes aspiration risk and facilitates lung expansion. Coupled with consistent oral care, this positioning significantly lowers bacterial colonization and the likelihood of pneumonia (Fortaleza et al., 2020).	Question: Should chlorhexidine be prioritized over standard oral hygiene practices?Answer: Chlorhexidine (0.2%) effectively reduces bacterial load, but long-term or frequent use may cause mucosal irritation. Therefore, it should be used in conjunction with routine toothbrushing and oral suctioning to maintain a balanced approach to infection prevention (Prasad et al., 2019; Vieira et al., 2020).

Conclusion

Enhancing critical thinking among nursing staff is pivotal to combating ventilator-associated pneumonia and other hospital-acquired infections. This case highlights how integrating pathophysiological understanding, clinical assessment skills, and pharmacological knowledge drives informed decision-making. Employing evidence-based bundles, regular evaluations, and targeted pharmacologic strategies ensures comprehensive patient protection, leading to safer clinical environments and improved healthcare outcomes.

References

Álvarez-Lerma, F., et al. (2018). Prevention of ventilator-associated pneumonia. Critical Care Medicine, 46(2), 181–188. https://doi.org/10.1097/ccm.0000000000002736

Bardia, A., et al. (2019). Preoperative chlorhexidine mouthwash to reduce pneumonia after cardiac surgery: A systematic review and meta-analysis. The Journal of Thoracic and Cardiovascular Surgery, 158(4), 1094–1100. https://doi.org/10.1016/j.jtcvs.2019.01.014

Fortaleza, C., et al. (2020). Sustained reduction of healthcare-associated infections after the introduction of a bundle for prevention of ventilator-associated pneumonia in medical-surgical intensive care units. The Brazilian Journal of Infectious Diseases, 24(5), 373–379. https://doi.org/10.1016/j.bjid.2020.08.004

Hellyer, T., et al. (2016). The intensive care society recommended bundle of interventions for the prevention of ventilator-associated pneumonia. Journal of the Intensive Care Society, 17(3), 238–243. https://doi.org/10.1177/1751143716644461

Hua, F., et al. (2016). Oral hygiene care for critically ill patients to prevent ventilator-associated pneumonia. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.cd008367.pub3

Khan, Z., et al. (2017). Ventilator-associated pneumonia or ventilator-induced pneumonia. Multidisciplinary Respiratory Medicine, 12, 224. https://doi.org/10.4081/mrm.2017.224

Olanipekun, T., & Snyder, R. (2019). Mortality risk in ventilator-acquired bacterial pneumonia and nonventilator ICU-acquired bacterial pneumonia. Critical Care Medicine, 47(10), e851–e852. https://doi.org/10.1097/ccm.0000000000003662

Pinho, R., et al. (2020). Impact of each component of a ventilator bundle on preventing ventilator-associated pneumonia and lower respiratory infection. Infection Control & Hospital Epidemiology, 41(S1), s259–s260. https://doi.org/10.1017/ice.2020.824

Prasad, R., et al. (2019). The impact of 0.2% chlorhexidine gel on oral health and the incidence of pneumonia amongst adults with profound complex neurodisability. Special Care in Dentistry, 39(5), 524–532. https://doi.org/10.1111/scd.12414

Vieira, P., et al. (2020). Should oral chlorhexidine remain in ventilator-associated pneumonia prevention bundles? Medicina Intensiva. https://doi.org/10.1016/j.medin.2020.09.009

NR 536 Week 3 Developing Critical Thinking Questions

Xie, X., et al. (2019). Drug prevention and control of ventilator-associated pneumonia. Frontiers in Pharmacology, 10, 298. https://doi.org/10.3389/fphar.2019.00298

Zampieri, F., et al. (2015). Nebulized antibiotics for ventilator-associated pneumonia: A systematic review and meta-analysis. Critical Care, 19, 86. https://doi.org/10.1186/s13054-015-0868-y

Zhao, J., et al. (2020). Do probiotics help prevent ventilator-associated pneumonia in critically ill patients? A systematic review with meta-analysis. ERJ Open Research, 6(2), 00302–2020. https://doi.org/10.1183/23120541.00302-2020